However, our previous observations that exogenous analogs of itaconate can improve NZB/W F1, another lupus mouse model, and that levels of ACOD1 decrease in these genetically prone mouse model as nephritis progresses, suggests that these observations are not model-dependent. This evidence concerns the gene ACOD1 and systemic lupus erythematosus.